Clinical trial

Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer

NCT05251766

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-04-20

PhasePHASE1

Study timeline

Study start (estimated)2022-04-20Date precision: day

Registry last updated2022-02-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Chemotherapy Effectunresolved

Interventions

Nab paclitaxelDRUG

DocetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

Xuli Menglead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05251766 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.